Log In
Print this Print this

Intercept Blood System for red blood cells

  Manage Alerts
Collapse Summary General Information
Company Cerus Corp.
DescriptionPathogen inactivation system using S-303 pH-activated compound
Molecular Target DNA ; RNA
Mechanism of Action 
Therapeutic ModalityMedical Devices

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Get a free BioCentury trial today